vs
Side-by-side financial comparison of 4D Molecular Therapeutics, Inc. (FDMT) and FIRSTSUN CAPITAL BANCORP (FSUN). Click either name above to swap in a different company.
FIRSTSUN CAPITAL BANCORP is the larger business by last-quarter revenue ($110.0M vs $85.1M, roughly 1.3× 4D Molecular Therapeutics, Inc.). 4D Molecular Therapeutics, Inc. runs the higher net margin — 22.8% vs 19.6%, a 3.2% gap on every dollar of revenue. Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 6.9%).
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
FirstSun Capital Bancorp is a U.S.-headquartered financial holding company that offers a comprehensive range of banking and financial services, including commercial and consumer lending, deposit products, wealth management, and treasury solutions. It mainly serves individual customers, small and medium-sized enterprises, and corporate clients across U.S. regional markets.
FDMT vs FSUN — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $85.1M | $110.0M |
| Net Profit | $19.4M | $21.6M |
| Gross Margin | — | — |
| Operating Margin | 17.3% | — |
| Net Margin | 22.8% | 19.6% |
| Revenue YoY | 8508900.0% | — |
| Net Profit YoY | 139.1% | -8.4% |
| EPS (diluted) | $0.43 | $0.76 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $110.0M | ||
| Q4 25 | $85.1M | $110.2M | ||
| Q3 25 | $90.0K | $107.3M | ||
| Q2 25 | $15.0K | $105.6M | ||
| Q1 25 | $14.0K | $96.2M | ||
| Q4 24 | $1.0K | $98.7M | ||
| Q3 24 | $3.0K | $98.2M | ||
| Q2 24 | $5.0K | $96.2M |
| Q1 26 | — | $21.6M | ||
| Q4 25 | $19.4M | $24.8M | ||
| Q3 25 | $-56.9M | $23.2M | ||
| Q2 25 | $-54.7M | $26.4M | ||
| Q1 25 | $-48.0M | $23.6M | ||
| Q4 24 | — | $16.4M | ||
| Q3 24 | $-43.8M | $22.4M | ||
| Q2 24 | $-35.0M | $24.6M |
| Q1 26 | — | — | ||
| Q4 25 | 17.3% | 29.0% | ||
| Q3 25 | -67983.3% | 26.4% | ||
| Q2 25 | -396373.3% | 31.2% | ||
| Q1 25 | -383007.1% | 30.9% | ||
| Q4 24 | — | 20.4% | ||
| Q3 24 | -1704400.0% | 29.1% | ||
| Q2 24 | -849120.0% | 32.3% |
| Q1 26 | — | 19.6% | ||
| Q4 25 | 22.8% | 22.5% | ||
| Q3 25 | -63195.6% | 21.6% | ||
| Q2 25 | -364386.7% | 25.0% | ||
| Q1 25 | -342657.1% | 24.5% | ||
| Q4 24 | — | 16.6% | ||
| Q3 24 | -1461433.3% | 22.8% | ||
| Q2 24 | -699060.0% | 25.5% |
| Q1 26 | — | $0.76 | ||
| Q4 25 | $0.43 | $0.89 | ||
| Q3 25 | $-1.01 | $0.82 | ||
| Q2 25 | $-0.98 | $0.93 | ||
| Q1 25 | $-0.86 | $0.83 | ||
| Q4 24 | — | $0.57 | ||
| Q3 24 | $-0.79 | $0.79 | ||
| Q2 24 | $-0.63 | $0.88 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $402.7M | $413.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $505.7M | $1.2B |
| Total Assets | $566.7M | $8.6B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $413.7M | ||
| Q4 25 | $402.7M | $652.6M | ||
| Q3 25 | $305.1M | $659.9M | ||
| Q2 25 | $293.2M | $785.1M | ||
| Q1 25 | $321.4M | $621.4M | ||
| Q4 24 | $424.9M | $615.9M | ||
| Q3 24 | $501.9M | $573.7M | ||
| Q2 24 | $541.9M | $535.8M |
| Q1 26 | — | $1.2B | ||
| Q4 25 | $505.7M | $1.2B | ||
| Q3 25 | $369.0M | $1.1B | ||
| Q2 25 | $420.9M | $1.1B | ||
| Q1 25 | $469.7M | $1.1B | ||
| Q4 24 | $510.6M | $1.0B | ||
| Q3 24 | $552.9M | $1.0B | ||
| Q2 24 | $588.3M | $996.6M |
| Q1 26 | — | $8.6B | ||
| Q4 25 | $566.7M | $8.5B | ||
| Q3 25 | $424.0M | $8.5B | ||
| Q2 25 | $473.6M | $8.4B | ||
| Q1 25 | $515.7M | $8.2B | ||
| Q4 24 | $560.4M | $8.1B | ||
| Q3 24 | $604.0M | $8.1B | ||
| Q2 24 | $620.1M | $8.0B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.6M | — |
| Free Cash FlowOCF − Capex | $28.5M | — |
| FCF MarginFCF / Revenue | 33.5% | — |
| Capex IntensityCapex / Revenue | 0.1% | — |
| Cash ConversionOCF / Net Profit | 1.47× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-109.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $28.6M | $111.5M | ||
| Q3 25 | $-46.5M | $49.4M | ||
| Q2 25 | $-43.4M | $15.0M | ||
| Q1 25 | $-47.8M | $26.4M | ||
| Q4 24 | $-134.6M | $101.1M | ||
| Q3 24 | $-29.4M | $48.1M | ||
| Q2 24 | $-30.2M | $20.9M |
| Q1 26 | — | — | ||
| Q4 25 | $28.5M | $104.0M | ||
| Q3 25 | $-46.6M | $47.6M | ||
| Q2 25 | $-43.4M | $13.0M | ||
| Q1 25 | $-48.4M | $24.3M | ||
| Q4 24 | $-138.4M | $95.7M | ||
| Q3 24 | $-31.2M | $47.1M | ||
| Q2 24 | $-30.6M | $19.9M |
| Q1 26 | — | — | ||
| Q4 25 | 33.5% | 94.3% | ||
| Q3 25 | -51765.6% | 44.4% | ||
| Q2 25 | -289620.0% | 12.3% | ||
| Q1 25 | -345635.7% | 25.3% | ||
| Q4 24 | -13837100.0% | 97.0% | ||
| Q3 24 | -1038966.7% | 47.9% | ||
| Q2 24 | -611840.0% | 20.6% |
| Q1 26 | — | — | ||
| Q4 25 | 0.1% | 6.8% | ||
| Q3 25 | 101.1% | 1.6% | ||
| Q2 25 | 440.0% | 1.9% | ||
| Q1 25 | 4507.1% | 2.1% | ||
| Q4 24 | 378600.0% | 5.5% | ||
| Q3 24 | 59266.7% | 1.1% | ||
| Q2 24 | 6980.0% | 1.1% |
| Q1 26 | — | — | ||
| Q4 25 | 1.47× | 4.49× | ||
| Q3 25 | — | 2.13× | ||
| Q2 25 | — | 0.57× | ||
| Q1 25 | — | 1.12× | ||
| Q4 24 | — | 6.18× | ||
| Q3 24 | — | 2.15× | ||
| Q2 24 | — | 0.85× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FDMT
Segment breakdown not available.
FSUN
| Net Interest Income | $82.8M | 75% |
| Noninterest Income | $27.2M | 25% |
